These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27751758)

  • 21. Selection and identification of anaerobic lactobacilli producing inhibitory compounds against vaginal pathogens.
    Kaewsrichan J; Peeyananjarassri K; Kongprasertkit J
    FEMS Immunol Med Microbiol; 2006 Oct; 48(1):75-83. PubMed ID: 16965354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of the prevalence of antimicrobial resistance genes in canine Clostridium perfringens isolates.
    Kather EJ; Marks SL; Foley JE
    Vet Microbiol; 2006 Mar; 113(1-2):97-101. PubMed ID: 16330169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defence factors of vaginal lactobacilli.
    Kovachev S
    Crit Rev Microbiol; 2018 Feb; 44(1):31-39. PubMed ID: 28418713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lactobacillus species isolated from the vagina: identification, hydrogen peroxide production and nonoxynol-9 resistance.
    Pascual LM; Daniele MB; Pájaro C; Barberis L
    Contraception; 2006 Jan; 73(1):78-81. PubMed ID: 16371300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urogenital pathogen inhibition and compatibility between vaginal Lactobacillus strains to be considered as probiotic candidates.
    Juárez Tomás MS; Saralegui Duhart CI; De Gregorio PR; Vera Pingitore E; Nader-Macías ME
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):399-406. PubMed ID: 21862199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaginal pH measured in vivo: lactobacilli determine pH and lactic acid concentration.
    O'Hanlon DE; Come RA; Moench TR
    BMC Microbiol; 2019 Jan; 19(1):13. PubMed ID: 30642259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro inhibitory activity of human vaginal lactobacilli against pathogenic bacteria associated with bacterial vaginosis in Kenyan women.
    Matu MN; Orinda GO; Njagi EN; Cohen CR; Bukusi EA
    Anaerobe; 2010 Jun; 16(3):210-5. PubMed ID: 19925874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exogenous lysozyme influences Clostridium perfringens colonization and intestinal barrier function in broiler chickens.
    Liu D; Guo Y; Wang Z; Yuan J
    Avian Pathol; 2010 Feb; 39(1):17-24. PubMed ID: 20390532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida.
    Strus M; Kucharska A; Kukla G; Brzychczy-Włoch M; Maresz K; Heczko PB
    Infect Dis Obstet Gynecol; 2005 Jun; 13(2):69-75. PubMed ID: 16011996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro antibacterial activity of antiseptics against vaginal lactobacilli.
    Juliano C; Piu L; Gavini E; Zanetti S; Fadda G
    Eur J Clin Microbiol Infect Dis; 1992 Dec; 11(12):1166-9. PubMed ID: 1291315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The in-vitro susceptibilities of vaginal lactobacilli to four broad-spectrum antibiotics, as determined by the agar dilution and E test methods.
    Herra CM; Cafferkey MT; Keane CT
    J Antimicrob Chemother; 1995 Jun; 35(6):775-83. PubMed ID: 7559189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaginal Lactobacilli Reduce
    Foschi C; Salvo M; Cevenini R; Parolin C; Vitali B; Marangoni A
    Front Cell Infect Microbiol; 2017; 7():502. PubMed ID: 29270390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and plasmid profiles of Lactobacillus species from the vagina of 100 healthy women.
    Reid G; McGroarty JA; Tomeczek L; Bruce AW
    FEMS Immunol Med Microbiol; 1996 Aug; 15(1):23-6. PubMed ID: 8871112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of phenotypic and genotypic antibiotic susceptibility of vaginal Lactobacillus sp.
    Štšepetova J; Taelma H; Smidt I; Hütt P; Lapp E; Aotäht E; Mändar R
    J Appl Microbiol; 2017 Aug; 123(2):524-534. PubMed ID: 28574626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydrogen peroxide producing lactobacilli in women with vaginal infections.
    Mijac VD; Dukić SV; Opavski NZ; Dukić MK; Ranin LT
    Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):69-76. PubMed ID: 16814920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular identification of vaginal lactobacilli isolated from Bulgarian women.
    Stoyancheva GD; Danova ST; Boudakov IY
    Antonie Van Leeuwenhoek; 2006 Oct; 90(3):201-10. PubMed ID: 16871423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of farnesol against vaginal Lactobacillus spp.
    Wang F; Liu Z; Zhang D; Niu X
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():25-29. PubMed ID: 28329720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Essential oil combinations against Clostridium perfringens and Clostridium septicum - the causative agents of gas gangrene.
    Ahmed Khan R; van Vuuren SF
    J Appl Microbiol; 2021 Sep; 131(3):1177-1192. PubMed ID: 33555103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hydrogen peroxide-producing Lactobacillus species in healthy women and in women with bacterial vaginosis].
    Shopova E
    Akush Ginekol (Sofiia); 2003; 42 Suppl 1():12-5. PubMed ID: 12858496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of agar plate and real-time PCR on enumeration of Lactobacillus, Clostridium perfringens and total anaerobic bacteria in dog faeces.
    Fu CJ; Carter JN; Li Y; Porter JH; Kerley MS
    Lett Appl Microbiol; 2006 May; 42(5):490-4. PubMed ID: 16620208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.